Bone Biologics (BBLG) Interest Expenses (2014 - 2021)
Bone Biologics (BBLG) reported Interest Expenses of $14755.0 for Q4 2021, down 94.03% year-over-year from $247279.0 in Q4 2020, and down 94.72% quarter-over-quarter from $279514.0 in Q3 2021.
Bone Biologics (BBLG) Interest Expenses (2014 - 2021) Analysis & Trends
Bone Biologics (BBLG) has 8 years of Interest Expenses data on file, last reported at $14755.0 in Q4 2021.
- Interest Expenses for Q4 2021 came in at $14755.0, down 94.03% year-over-year; the trailing twelve-month figure through Sep 2022 was $14755.0 (down 98.58% YoY), and the FY2021 annual result was $805109.0, down 19.33% from the prior year.
- Interest Expenses declined to $14755.0 in Q4 2021 per BBLG's latest filing, from $279514.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $1.5 million in Q4 2017 and troughed at $14755.0 in Q4 2021.
- A 5-year average of $421591.4 and a median of $254402.0 in 2019 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2017 and 2021: Interest Expenses jumped 243.75% in 2017, then plunged 94.03% in 2021.
- A 5-year view of Interest Expenses shows it stood at $1.5 million in 2017, then slumped by 84.12% to $231760.0 in 2018, then advanced by 9.4% to $253554.0 in 2019, then declined by 2.47% to $247279.0 in 2020, then sank by 94.03% to $14755.0 in 2021.
- Business Quant data shows BBLG's Interest Expenses at $14755.0 in Q4 2021, $279514.0 in Q3 2021, and $260017.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 14,755.00 |
| Dec 31, 2021 | 14,755.00 |
| Sep 30, 2021 | 279,514.00 |
| Sep 30, 2021 | 279,514.00 |
| Jun 30, 2021 | 260,017.00 |
| Jun 30, 2021 | 260,017.00 |
| Mar 31, 2021 | 250,823.00 |
| Mar 31, 2021 | 250,823.00 |
| Dec 31, 2020 | 247,279.00 |
| Dec 31, 2020 | 247,279.00 |
| Sep 30, 2020 | 248,226.00 |
| Sep 30, 2020 | 248,226.00 |
| Jun 30, 2020 | 247,321.00 |
| Jun 30, 2020 | 247,321.00 |
| Mar 31, 2020 | 255,250.00 |
| Mar 31, 2020 | 255,250.00 |
| Dec 31, 2019 | 253,554.00 |
| Dec 31, 2019 | 253,554.00 |
| Sep 30, 2019 | 260,070.00 |
| Sep 30, 2019 | 260,070.00 |